XNYS · Healthcare · Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | FY 2025 | 1.89 | 1.02 | -46.03% | $6.16B | ❌ Miss | +0.00% | -3.48% | +3.41% |
| 2025-02-25 | FY 2024 | — | 0.84 | — | $5.81B | — | +2.88% | +6.72% | +1.07% |
| 2024-08-01 |
| H1 2024 |
| — |
| 0.38 |
| — |
| $2.83B |
| — |
| -0.98% |
| -1.95% |
| -0.29% |
| 2024-02-27 | FY 2023 | — | 0.83 | — | $5.55B | — | — | — | — |
| 2023-02-21 | FY 2022 | — | 0.82 | — | $5.21B | — | -0.37% | -2.82% | -4.49% |
Showing last 5 quarters.